The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder

References

• Abou-Auda HS, Al-Yamani MJ, Abou-Shaaban RR, Khoshhal SI. 2008. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. Bipolar Disord 10:369–376.
   Google Scholar
• Adams J, Scott J. 2000. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 101:119–124.
   PubMed Web of Science ®Google Scholar
• Agarkar S, Mahgoub N, Young RC. 2011. Use of transcranial magnetic stimulation in bipolar disorder. J Neuropsychiatry Clin Neurosci 23:E12–13.
   Google Scholar
• Ahlfors UG, Baastrup PC, Dencker SJ, Elgen K, Lingjaerde O, Pedersen V, . 1981. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr Scand 64:226–237.
   PubMed Web of Science ®Google Scholar
• Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL. 2006. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 163:272–275.
   PubMed Web of Science ®Google Scholar
• Altamura AC, Salvadori D, Madaro D, Santini A, Mundo E. 2003. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. J Affect Disord 76:267–271.
   PubMed Web of Science ®Google Scholar
• Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, . 2003. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 160:1252–1262.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Black DO, Keck PE Jr, Nolen WA, Frye MA, . 2006. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 67:1551–1560.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, . 2009. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry 70:450–457.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th revised ed. Washington, DC: American Psychiatric Press.
   Google Scholar
• Amsterdam JD, Shults J. 2005. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 20:257–264.
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Shults J. 2010. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry 167:792–800.
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, . 1998. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 18:435–440.
   PubMed Web of Science ®Google Scholar
• Anderson J. 2000. On variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression. J Rheumatol 27:540–542.
   PubMedGoogle Scholar
• Angst F, Stassen HH, Clayton PJ, Angst J. 2002. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord 68:167–181.
   PubMed Web of Science ®Google Scholar
• Angst J. 1981. Course of affective disorders. In: van Praag HM, Lader HM, Rafaelson OJ, Sachar EJ, editors. Handbook of Biological Psychiatry. New York: Marcel Dekker. p 225–242.
   Google Scholar
• Angst J, Preisig M. 1995. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 146:17–23.
   PubMedGoogle Scholar
• Angst J, Angst F, Gerber-Werder R, Gamma A. 2005. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch Suicide Res 9:279–300.
   PubMedGoogle Scholar
• Baastrup PC, Schou M. 1967. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16:162–172.
   PubMed Web of Science ®Google Scholar
• Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. 1970. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 2:326–330.
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L, Hennen J. 1999a. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 60:77–84.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Hennen J, Floris G. 1999b. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord 1:91–97.
   Google Scholar
• Baldessarini RJ, Tondo L, Viguera AC. 1999c. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1:17–24.
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. 2006. Decreased risk of suicides and atempts during long-term lithium treatment: A meta-analytic review. Bipolar Disord 8:625–639.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J, . 2008. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9:248–312.
   PubMed Web of Science ®Google Scholar
• Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, . 2006. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 67:48–55.
   PubMed Web of Science ®Google Scholar
• Bech P, Vendsborg PB, Rafaelsen OJ. 1976. Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiatr Scand 53:70–81.
   PubMed Web of Science ®Google Scholar
• Becker D, Grinberg Y, Weizman A, Mester R. 2002. Association between flupenthixol treatment and emergence of manic symptoms. Eur Psychiatry 17:349–352.
   PubMed Web of Science ®Google Scholar
• Belmaker RH, Bersudsky Y, Lichtenberg P. 2010. Bayesian approach to bipolar guidelines. World J Biol Psychiatry 11:76–77.
   Web of Science ®Google Scholar
• Benabarre A, Castro P, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Murru A, . 2009. Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder. Actas Esp Psiquiatr 37:143–147.
   PubMed Web of Science ®Google Scholar
• Bendz H, Schon S, Attman PO, Aurell M. 2010. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77:219–224.
   PubMed Web of Science ®Google Scholar
• Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, . 2008a. N-Acetyl cysteine for depressive symptoms in bipolar disorder–-a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468–475.
   PubMed Web of Science ®Google Scholar
• Berk M, Ng F, Wang WV, Calabrese JR, Mitchell PB, Malhi GS, Tohen M. 2008b. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord 106:153–158.
   PubMed Web of Science ®Google Scholar
• Berwaerts J, Melkote R, Nuamah I, Lim P. 2012. A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode. J Affect Disord 138:247–258.
   PubMed Web of Science ®Google Scholar
• Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR. 2008. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry 192:5–11.
   PubMed Web of Science ®Google Scholar
• Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR. 2009. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials. J Psychopharmacol 23:574–591.
   PubMedGoogle Scholar
• Bond DJ, Noronha MM, Kauer-Sant'Anna M, Lam RW, Yatham LN. 2008. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: A systematic review and meta-analysis. J Clin Psychiatry 69:1589–1601.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, . 2010. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 121:156–160.
   PubMed Web of Science ®Google Scholar
• Born C, Dittmann S, Post RM, Grunze H. 2005. Newer prophylactic agents for bipolar disorder and their influence on suicidality. Arch Suicide Res 9:301–306.
   PubMedGoogle Scholar
• Bowden CL, Swann AC, Calabrese JR, McElroy SL, Morris D, Petty F, . 1997. Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. Psychopharmacol Bull 33:693–699.
   PubMedGoogle Scholar
• Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, . 2000. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57:481–489.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, . 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392–400.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M. 2010. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. J Clin Psychiatry 71:130–137.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Singh V, Weisler R, Thompson P, Chang X, Quinones M, Mintz J. 2012. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatry 64:1013–1024.
   Google Scholar
• Calabrese JR, Meltzer HY, Markovitz PJ. 1991. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 11:396–397.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, . 2000. A double–blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61:841–850.
   PubMed Web of Science ®Google Scholar
• Calabrese J, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen O-P, , for the Lamictal 605 Study group. 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin
   Google Scholar
• Calabrese JR, Vieta E, El Mallakh R, Findling RL, Youngstrom EA, Elhaj O, . 2004. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry 56:957–963.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, . 2005. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 162:2152–2161.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, . 2006. Recurrence in bipolar I disorder: a post-hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry 59:1061–1064.
   Google Scholar
• Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, . 2012. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disord 14:41–53.
   PubMed Web of Science ®Google Scholar
• Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B. 2003. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord 75:83–91.
   PubMed Web of Science ®Google Scholar
• Carta MG, Zairo F, Mellino G, Hardoy MC, Vieta E. 2006. An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients. Clin Pract Epidemiol Ment Health 2:19.
   PubMedGoogle Scholar
• Chengappa KN, Hennen J, Baldessarini RJ, Kupfer DJ, Yatham LN, Gershon S, . 2005. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord 7:68–76.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Pretty H, Hawton K, Geddes JR. 2005. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805–1819.
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J. 2006. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 93:13–17.
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Sanchez-Moreno J, Goikolea JM, Popova E, Bonnin CM, Scott J. 2009. Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. J Affect Disord 112:30–35.
   PubMed Web of Science ®Google Scholar
• Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF. 2006. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. J Clin Psychiatry 67:798–806.
   PubMed Web of Science ®Google Scholar
• Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. 1993. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720–727.
   PubMed Web of Science ®Google Scholar
• Coxhead N, Silverstone T, Cookson J. 1992. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 85:114–118.
   PubMed Web of Science ®Google Scholar
• Cundall RL, Brooks PW, Murray LG. 1972. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2:308–311.
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Smith-Jackson EE, Bryan AL, Ali SO, Post RM. 1997a. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry 154:1456–1458.
   PubMedGoogle Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. 1997b. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 58:470–478.
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Ali SO, Sollinger AB, Smith-Jackson EE, Leverich GS, Post RM. 2002. Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder. Depress Anxiety 15:1–9.
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, . 2005. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 66:317–322.
   PubMed Web of Science ®Google Scholar
• Dickerson FB, Boronow JJ, Stallings CR, Origoni AE, Cole S, Yolken RH. 2004. Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatr Serv 55:54–58.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Dubovsky AN. 2011. Ziprasidone for maintenance treatment of bipolar I disorder in adults. Expert Opin Pharmacother 12:817–824.
   PubMed Web of Science ®Google Scholar
• Duffy A, Milin R, Grof P. 2009. Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine. BMC Psychiatry 9:4.
   PubMed Web of Science ®Google Scholar
• Dunner DL. 1998. Lithium carbonate: maintenance studies and consequences of withdrawal. J Clin Psychiatry 59(Suppl 6):48–55; discussion 56.
   Google Scholar
• Dunner DL, Fieve RR. 1974. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30:229–233.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Ghaemi SN, Sagduyu K, Thase ME, Wisniewski SR, Nierenberg AA, . 2008. Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. J Affect Disord 111:372–377.
   PubMed Web of Science ®Google Scholar
• Elphick M. 1985. An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics. Br J Psychiatry 147:198–200.
   PubMed Web of Science ®Google Scholar
• Emrich HM, Wolf R. 1992. Valproate treatment of mania. Prog Neuropsychopharmacol Biol Psychiatry 16:691–701.
   Google Scholar
• Ernst CL, Goldberg JF. 2002. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry 63(Suppl 4):42–55.
   PubMedGoogle Scholar
• Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AH, Hopwood SE. 1986. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 148:723–725.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. 2003. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 160:112–117.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. 2005. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7:424–430.
   PubMed Web of Science ®Google Scholar
• Fieve RR, Kumbaraci T, Dunner DL. 1976. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 133:925–929.
   PubMed Web of Science ®Google Scholar
• Findling RL, Youngstrom EA, McNamara NK, Stansbrey RJ, Wynbrandt JL, Adegbite C, . 2012. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. J Clin Psychiatry 73:57–63.
   PubMed Web of Science ®Google Scholar
• Fitzgerald BJ, Okos AJ. 2002. Elevation of carbamazepine-10,11-epoxide by quetiapine. Pharmacotherapy 22:1500–1503.
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Vieta E. 2009. Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Ann Gen Psychiatry 8:16.:16.
   PubMedGoogle Scholar
• Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G. 2004. Report of three cases that received maintenance treatment with risperidone as a mood stabilizer. Ann Gen Hosp Psychiatry 3:10.
   Google Scholar
• Fountoulakis KN, Gonda X, Samara M, Siapera M, Karavelas V, Ristic DI, Iacovides A. 2012. Antiepileptic drugs and suicidality. J Psychopharmacol 26:1401–1407.
   PubMed Web of Science ®Google Scholar
• Franchini L, Zanardi R, Smeraldi E, Gasperini M. 1999. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 249:227–230.
   PubMed Web of Science ®Google Scholar
• Frangou S, Lewis M, McCrone P. 2006. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188:46–50.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, . 1991. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851–855.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Freeman SA. 2006. Lithium: clinical considerations in internal medicine. Am J Med 119:478–481.
   PubMed Web of Science ®Google Scholar
• Frye MA. 2011. Clinical practice. Bipolar disorder – a focus on depression. New Engl J Med 364:51–59.
   PubMed Web of Science ®Google Scholar
• Frye MA, Altshuler LL, Bitran JA. 1996. Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol 16:87–90.
   PubMedGoogle Scholar
• Frye MA, Yatham LN, Calabrese JR, Bowden CL, Ketter TA, Suppes T, . 2006. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry 67:1721–1728.
   PubMed Web of Science ®Google Scholar
• Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, . 2009. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 166:164–172.
   PubMed Web of Science ®Google Scholar
• Garcia-Lopez A, Ezquiaga E, Nieves P, Rodriguez-Salvanes F. 2001. Factores predictores de respuesta al litio en pacientes bipolares en seguimiento a largo plazo. Actas Esp Psiquiatr 29:327–332.
   Google Scholar
• Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. 2004. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217–222.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, . 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375:385–395.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN. 2008. Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers? Am J Psychiatry 165:300–302.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Sachs GS. 1997. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 12:333–338.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Hsu DJ, Rosenquist KJ, Katzow JJ, Goodwin FK. 2004. Long-term observational comparison of risperidone and olanzapine in bipolar disorder. Ann Clin Psychiatry 16:69–73.
   PubMedGoogle Scholar
• Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, Sachs G. 2006. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv 57:660–665.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ. 2008. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 118:347–356.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, . 2010. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 71:372–380.
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, H . 2007. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 164:1356–1363.
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Hur K, Brown CH, Mann JJ. 2009. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 66:1354–1360.
   PubMed Web of Science ®Google Scholar
• Gitlin M. 1999. Lithium and the kidney: an updated review. Drug Saf 20:231–243.
   PubMedGoogle Scholar
• Gitlin MJ, Swendsen J, Heller TL, Hammen C. 1995. Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635–1640.
   PubMed Web of Science ®Google Scholar
• Gitlin MJ, Abulseoud O, Frye MA. 2010. Improving the design of maintenance studies for bipolar disorder. Curr Med Res Opin 26:1835–1842.
   PubMed Web of Science ®Google Scholar
• Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E. 2007. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 9:45–52.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, . 2008. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 63:125–130.
   Google Scholar
• Goldberg JF, Brooks JO III, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, . 2009a. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry 70:155–162.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Brooks JO III, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, . 2009b. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry 70:155–162.
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. 2003. Lamotrigine: a review of its use in bipolar disorder. Drugs 63:2029–2050.
   PubMed Web of Science ®Google Scholar
• Goncalves N, Stoll K-D. 1985. Carbamazepin bei manischen Syndromen. Eine kontrollierte Doppelblind-Studie. Nervenarzt 56:43–47.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Pinto A, Mosquera F, Alonso M, Lopez P, Ramirez F, Vieta E, Baldessarini RJ. 2006. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord 8:618–624.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Pinto A, Vieta E, Reed C, Novick D, Barraco A, Aguado J, Haro JM. 2011. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania – results of a two year observational study in bipolar disorder (EMBLEM). J Affect Disord 131:320–329.
   PubMed Web of Science ®Google Scholar
• Goodwin FK. 2002. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 63 Suppl 10:5–12.
   Google Scholar
• Goodwin FK, Jamison KR. 2007. Manic-depressive illness. 2nd ed. New York: Oxford University Press.
   Google Scholar
• Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. 2003. Suicide risk in bipolar disorder during treatment with lithium and divalproex. J Am Med Assoc 290:1467–1473.
   PubMed Web of Science ®Google Scholar
• Goodwin GM. 1994. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164:149–152.
   PubMed Web of Science ®Google Scholar
• Goodwin GM. 2009. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346–388.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, . 2004. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432–441.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E. 2008. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 18:787–793.
   PubMed Web of Science ®Google Scholar
• Grande I, Balanza-Martinez V, Jimenez-Arriero M, Iglesias Lorenzo FG, Franch Valverde JI, de AR, . 2012a. Clinical factors leading to lamotrigine prescription in bipolar outpatients: Subanalysis of the SIN-DEPRES study. J Affect Disord 143:102–108.
   Google Scholar
• Grande I, de AR, Jimenez-Arriero MA, Lorenzo FG, Valverde JI, Balanza-Martinez V, . 2012b. Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). Int J Neuropsychopharmacol Apr 27:1–11. [Epub ahead of print].
   Google Scholar
• Greil W, Kleindienst N. 1999a. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 14:283–285.
   PubMedGoogle Scholar
• Greil W, Kleindienst N. 1999b. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 14:277–281.
   PubMedGoogle Scholar
• Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, . 1997a. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 247:42–50.
   PubMed Web of Science ®Google Scholar
• Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, . 1997b. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study. J Affect Disord 43:151–161.
   PubMed Web of Science ®Google Scholar
• Grof P. 1979. Some practical aspects of lithium treatment: blood levels, dosage prediction, and slow-release preparations. Arch Gen Psychiatry 36:891–893.
   Google Scholar
• Grof P. 2010. Sixty years of lithium responders. Neuropsychobiology 62:8–16.
   Google Scholar
• Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, . 2002. Is response to prophylactic lithium a familial trait?J Clin Psychiatry 63:942–947.
   PubMed Web of Science ®Google Scholar
• Grunze H. 2002. The search for the Holy Grail – the ideal mood stabilizer: fiction or future? In: Maj M, Akiskal H, Lopez-Ibor JJ, Sartorius N, editors. WPA Series “Evidence Experience in Psychiatry” – Bipolar disorder. Chichester: Wiley & Sons. p 229–232.
   Google Scholar
• Grunze H, Walden J. 2004. Valproat bei manisch-depressiven (bipolaren) Erkrankungen. 2nd ed. Stuttgart: Thieme Verlag.
   Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden CL, Möller H-J, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. 2004. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part III: Maintenance treatment. World J Biol Psychiatry 5:120–135.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S. 2009. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 10:85–116.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11:81–109.
   PubMed Web of Science ®Google Scholar
• Grunze HC. 2008. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr 13:790–795.
   PubMedGoogle Scholar
• Grunze HC. 2010. Anticonvulsants in bipolar disorder. J Ment Health 19:127–141.
   PubMed Web of Science ®Google Scholar
• Gyulai L, Bowden CL, McElroy SL, Calabrese JR, Petty F, Swann AC, . 2003. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 28:1374–1382.
   PubMed Web of Science ®Google Scholar
• Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF. 2004. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 110:383–392.
   PubMed Web of Science ®Google Scholar
• Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK. 2007. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1219–1223.
   PubMed Web of Science ®Google Scholar
• Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA. 2003. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 64:144–151.
   PubMed Web of Science ®Google Scholar
• Harvey PD. 2006. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry 67(Suppl 9):14–18; discussion 36–42.
   Google Scholar
• Harvey PW, Everett DJ, Springall CJ. 2008. Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 22(Suppl 2):20–27.
   Google Scholar
• Hawley CJ, Gale TM, Sivakumaran T. 2002. Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord 72:177–184.
   PubMed Web of Science ®Google Scholar
• Hayes SG. 1989. Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 50(Suppl):35–39.
   Google Scholar
• Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. 2006. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 163:185–194.
   PubMed Web of Science ®Google Scholar
• Hirschfeld R, Weisler RH, Keck PE. 1999. Cost-effectiveness evaluation of divalproex versus lithium in the treatment of bipolar disorder. In: 152nd APA Annual meeting abstracts. No. 686.
   Google Scholar
• Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. 2011. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68:128–137.
   PubMed Web of Science ®Google Scholar
• Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Garlow SJ, Barrocas A, . 2012. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 69:150–158.
   PubMed Web of Science ®Google Scholar
• Hullin RP, McDonald R, Allsopp MN. 1972. Prophylactic lithium in recurrent affective disorders. Lancet i:1044–1046.
   Google Scholar
• Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H. 2002. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders: a case series. Neuropsychobiology 45(Suppl 1):37–42.
   Google Scholar
• Jefferson JW. 2010. A clinician's guide to monitoring kidney function in lithium-treated patients. J Clin Psychiatry 71:1153–1157.
   PubMed Web of Science ®Google Scholar
• Johannessen SI, Landmark CJ. 2010. Antiepileptic drug interactions – principles and clinical implications. Curr Neuropharmacol 8:254–267.
   PubMed Web of Science ®Google Scholar
• Johnston AM, Eagles JM. 1999. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 175:336–339.
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Owens DG, Lambert MT, Crow TJ, Frith CD, Done DJ. 1990. Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. J Affect Disord 20:225–233.
   PubMed Web of Science ®Google Scholar
• Jones MW. 1998. Topiramate – safety and tolerability. Can J Neurol Sci 25:S13–S15.
   Web of Science ®Google Scholar
• Joyce PR. 1988. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 3:123–129.
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, Coryell W, Maser J, Rice JA, . 2003. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 73:19–32.
   PubMed Web of Science ®Google Scholar
• Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. 1982. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 39:1065–1069.
   PubMed Web of Science ®Google Scholar
• Kantrowitz JT, Citrome L. 2008. Olanzapine: review of safety 2008. Expert Opin Drug Saf 7:761–769.
   PubMed Web of Science ®Google Scholar
• Karayal ON, Anway SD, Batzar E, Vanderburg DG. 2011. Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone. J Clin Psychiatry 72:367–375.
   Google Scholar
• Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. 2003. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160:741–748.
   PubMed Web of Science ®Google Scholar
• Keck PE, Bowden CL, Meinhold JM, Gyulai L, Prihoda TJ, Baker JD, Wozniak PJ. 2005. Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy. Int J Psychiaty Clin Practice 9:271–277.
   PubMed Web of Science ®Google Scholar
• Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, . 2006a. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 67:626–637.
   PubMed Web of Science ®Google Scholar
• Keck PE, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, . 2006b. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60:1020–1022.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, . 2007. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 68:1480–1491.
   PubMed Web of Science ®Google Scholar
• Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, . 2009. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry 70:113–121.
   PubMed Web of Science ®Google Scholar
• Kemp DE, Karayal ON, Calabrese JR, Sachs GS, Pappadopulos E, Ice KS, . 2012. Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. Eur Neuropsychopharmacol 22:123–131.
   PubMed Web of Science ®Google Scholar
• Kessing LV. 1998a. Recurrence in affective disorders. Br J Psychiatry 172:23–28.
   PubMed Web of Science ®Google Scholar
• Kessing LV. 1998b. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 28:1027–1038.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Hellmund G, Andersen PK. 2011a. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol.
   Google Scholar
• Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. 2011b. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 199:57–63.
   PubMed Web of Science ®Google Scholar
• Ketter TA, Calabrese JR. 2002. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63:146–151.
   PubMed Web of Science ®Google Scholar
• Ketter TA, Jones M, Paulsson B. 2007. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. J Affect Disord 100(Suppl 1):S45–53 (Epub 26 March 2007).
   Google Scholar
• Kleindienst N, Severus WE, Greil W. 2007. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. Int Clin Psychopharmacol 22:125–131.
   PubMed Web of Science ®Google Scholar
• Kovacsics CE, Gottesman II, Gould TD. 2009. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 49:175–198.
   Google Scholar
• Kraepelin E. 1921. Manic-depressive insanity and paranoia. Translated by R. Mary Barclay from the Eighth German Edition of the “Text-Book of Psychiatry”, vol. iii, part ii, section on the Endogenous Dementias. Edited by George M. Robertson. E. & S. Livingstone, Edinburgh 1921, Chicago Medical Book Company, Chicago 1921.
   Google Scholar
• Kramer OH, Gottlicher M, Heinzel T. 2001. Histone deacetylase as a therapeutic target. Trends Endocrinol Metab 12:294–300.
   PubMed Web of Science ®Google Scholar
• Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. 2003. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 64:1483–1494.
   PubMed Web of Science ®Google Scholar
• Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE Jr, . 2005. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 162:1273–1280.
   PubMed Web of Science ®Google Scholar
• Lake CR, Hurwitz N. 2007. Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease – there is no schizoaffective disorder. Curr Opin Psychiatry 20:365–379.
   PubMed Web of Science ®Google Scholar
• Lambert PA. 1984. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Müller AA, editors. Anticonvulsants in affective disorders. Amsterdam, Oxford, Princeton: Elsevier Science Publishers. p 33–44.
   Google Scholar
• Lancon C, Llorca PM. 1996. Clozapine et traitement des troubles bipolaires a cycles rapides. Encephale 22:468–469.
   PubMedGoogle Scholar
• Lebowitz BK, Shear PK, Steed MA, Strakowski SM. 2001. Verbal fluency in mania: relationship to number of manic episodes. Neuropsychiatry Neuropsychol Behav Neurol 14:177–182.
   PubMedGoogle Scholar
• Leon AC, Solomon DA, Li C, Fiedorowicz JG, Coryell WH, Endicott J, Keller MB. 2011. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry 72:580–586.
   Google Scholar
• Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, . 2006. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 163:232–239.
   PubMed Web of Science ®Google Scholar
• Lexchin J, Light DW. 2006. Commercial influence and the content of medical journals. Br Med J 332:1444–1447.
   PubMed Web of Science ®Google Scholar
• Lexchin J, Bero LA, Djulbegovic B, Clark O. 2003. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 326:1167–1170.
   PubMed Web of Science ®Google Scholar
• Licht RW. 2012. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther 18:219–226.
   PubMed Web of Science ®Google Scholar
• Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. 2003. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl1–22.
   PubMedGoogle Scholar
• Licht RW, Vestergaard P, Brodersen A. 2008. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up. Bipolar Disord 10:79–86.
   PubMed Web of Science ®Google Scholar
• Licht RW, Nielsen JN, Gram LF, Vestergaard P, Bendz H. 2010. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 12:483–493.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, . 2005. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62:361–370.
   PubMed Web of Science ®Google Scholar
• Loo C, Katalinic N, Mitchell PB, Greenberg B. 2011. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord 132:1–13.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo C, Lopera-Vasquez J, Gallo A, Ospina-Duque J, Bell V, Torrent C, . 2010a. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 12:557–567.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo C, Lopera-Vasquez J, Ospina-Duque J, Garcia J, Gallo A, Cortez V, . 2010b. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 71:1055–1060.
   Web of Science ®Google Scholar
• Lusznat RM, Murphy DP, Nunn CM. 1988. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 153:198–204.
   PubMed Web of Science ®Google Scholar
• Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, . 2009. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar Disord 11:827–839.
   PubMed Web of Science ®Google Scholar
• Magalhaes PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, . 2011. N-Acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial. J Affect Disord 129:317–320.
   PubMed Web of Science ®Google Scholar
• Maier W, Möller HJ. 2010. Meta-analyses: a method to maximise the evidence from clinical studies? Eur Arch Psychiatry Clin Neurosci 260:17–23.
   PubMed Web of Science ®Google Scholar
• Maj M. 2000. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2:93–101.
   PubMed Web of Science ®Google Scholar
• Maj M, Pirozzi R, Magliano L, Bartoli L. 1998. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 155:30–35.
   PubMed Web of Science ®Google Scholar
• Malempati RN, Bond DJ, Yatham LN. 2008. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Int Clin Psychopharmacol 23:88–94.
   PubMed Web of Science ®Google Scholar
• Mander AJ, Loudon JB. 1988. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 2:15–17.
   PubMed Web of Science ®Google Scholar
• Marcotte D. 1998. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 50:245–251.
   PubMed Web of Science ®Google Scholar
• Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R. 2011. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord 13:133–144.
   PubMed Web of Science ®Google Scholar
• Marneros A. 2001. Expanding the group of bipolar disorders. J Affect Disord 62:39–44.
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, . 2007. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 9:103–113.
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Chengappa KN, Gershon S, Mullen J, Paulsson B. 2008. Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change. Bipolar Disord 10:566–579.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Bowden CL, Collins MA, Wozniak PJ, Keck PE Jr, Calabrese JR. 2008. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. J Affect Disord 107:127–133.
   Google Scholar
• McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, . 2010. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 71:163–174.
   PubMed Web of Science ®Google Scholar
• McIntyre RS. 2010. Aripiprazole for the maintenance treatment of bipolar I disorder: A review. Clin Ther 32(Suppl 1):S32–38.
   Google Scholar
• McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2009. Asenapine versus olanzapine in acute mania: a double-blind extension study. Bipolar Disord 11:815–826.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2010. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study. J Affect Disord 126:358–365.
   PubMed Web of Science ®Google Scholar
• McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, . 2005. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66:444–449.
   PubMed Web of Science ®Google Scholar
• McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. 2012. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379:721–728.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, . 2009. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New Engl J Med 360:1597–1605.
   PubMed Web of Science ®Google Scholar
• Melia PI. 1970. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 116:621–624.
   PubMedGoogle Scholar
• Meltzer HY, Baldessarini RJ. 2003. Reducing the risk for suicide in schizophrenia and affective disorders. J Clin Psychiatry 64:1122–1129.
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ. 2008. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 165:1408–1419.
   PubMed Web of Science ®Google Scholar
• Minnai GP, Salis PG, Oppo R, Loche AP, Scano F, Tondo L. 2011. Effectiveness of maintenance electroconvulsive therapy in rapid-cycling bipolar disorder. J ECT 27:123–126.
   Web of Science ®Google Scholar
• Mishory A, Winokur M, Bersudsky Y. 2003. Prophylactic effect of phenytoin in bipolar disorder: a controlled study. Bipolar Disord 5:464–467.
   Google Scholar
• Möller HJ, Maier W. 2010. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:25–39.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389.
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, . 2006. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193–198.
   PubMed Web of Science ®Google Scholar
• Moskowitz AS, Altshuler L. 1991. Increased sensitivity to lithium-induced neurotoxicity after stroke: a case report. J Clin Psychopharmacol 11:272–273.
   Google Scholar
• Müller-Oerlinghausen B, Ahrens B, Felber W. 2006. The suicide-preventive and mortality reducing effect of lithium. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry: The comprehensive guide. Oxfordshire, UK: Informa Healthcare. p 179–192.
   Google Scholar
• Murru A, Colom F, Nivoli A, Pacchiarotti I, Valenti M, Vieta E. 2011. When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. Eur Psychiatry.
   Google Scholar
• Muzina DJ, Momah C, Eudicone JM, Pikalov A, McQuade RD, Marcus RN, . 2008. Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. Int J Clin Pract 62:679–687.
   PubMed Web of Science ®Google Scholar
• Neels HM, Sierens AC, Naelaerts K, Scharpe SL, Hatfield GM, Lambert WE. 2004. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42:1228–1255.
   PubMed Web of Science ®Google Scholar
• Newcomer JW. 2007. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68 Suppl 4:8–13.:8–13.
   Google Scholar
• Nguyen HT, Sharma V, McIntyre RS. 2009. Teratogenesis associated with antibipolar agents. Adv Ther 26:281–294.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Kane JM, Correll CU. 2012. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study. Bipolar Disord 14:863–869.
   Google Scholar
• Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. 2008. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry 64:455–460.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Ketter TA, Calabrese JR, . 2009. Lithium treatment – moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clin Trials 6:637–648.
   Google Scholar
• Nolen WA, Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, . 2007. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand 115:360–365.
   PubMed Web of Science ®Google Scholar
• Nolen WA, Kupka RW, Schulte PFJ, Knoppert-van der Klein EAM, Honig A, Reichart CG, . 2008. Richtlijn bipolaire stoornissen. 2nd ed. UtrechtL De Tijdstrom uitgerverij BV.
   Google Scholar
• Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, . 1981. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berlin) 73:95–96.
   PubMed Web of Science ®Google Scholar
• Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, . 2011. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry 168:1050–1056.
   PubMedGoogle Scholar
• Pacchiarotti I, Mazzarini L, Kotzalidis GD, Valenti M, Nivoli AM, Sani G, . 2011. Mania and depression. Mixed, not stirred. J Affect Disord 133:105–113.
   PubMed Web of Science ®Google Scholar
• Park MH, Han C, Pae CU, Lee SJ, Patkar AA, Masand PS, Fleischhacker WW. 2011. Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. Expert Rev Neurother 11:1541–1552.
   PubMed Web of Science ®Google Scholar
• Parker G, Tully L, Olley A, Hadzi-Pavlovic D. 2006. SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study. J Affect Disord 92:205–214.
   PubMed Web of Science ®Google Scholar
• Passmore MJ, Garnham J, Duffy A, MacDougall M, Munro A, Slaney C, . 2003. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 5:110–114.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. 2005. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162:1957–1960.
   PubMed Web of Science ®Google Scholar
• Perova T, Kwan M, Li PP, Warsh JJ. 2010. Differential modulation of intracellular Ca2 + responses in B lymphoblasts by mood stabilizers. Int J Neuropsychopharmacol 13:693–702.
   PubMed Web of Science ®Google Scholar
• Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, Akiskal HS. 2002. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol 22:584–591.
   PubMed Web of Science ®Google Scholar
• Petrides G, Tobias KG, Kellner CH, Rudorfer MV. 2011. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology 64:129–140.
   PubMed Web of Science ®Google Scholar
• Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. 1986. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3–year trial in 83 patients. J Clin Psychiatry 47:490–494.
   PubMed Web of Science ®Google Scholar
• Popovic D, Reinares M, Goikolea JM, Bonnin CM, Gonzalez-Pinto A, Vieta E. 2011. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol.
   Google Scholar
• Post RM, Leverich GS, Altshuler L, Mikalauskas K. 1992. Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 149:1727–1729.
   PubMed Web of Science ®Google Scholar
• Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, . 2010a. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71:1176–1186.
   PubMedGoogle Scholar
• Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, . 2010b. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 71:864–872.
   PubMed Web of Science ®Google Scholar
• Potkin SG, Keck PE Jr, Segal S, Ice K, English P. 2005. Ziprasidone in acute bipolar mania: A 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25:301–310.
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM Jr, Klett CJ. 1973a. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 28:337–341.
   PubMed Web of Science ®Google Scholar
• Prien RF, Klett CJ, Caffey EM Jr. 1973b. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29:420–425.
   PubMed Web of Science ®Google Scholar
• Prien RF, Klett CJ, Caffey EM Jr. 1974. Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 131:198–203.
   PubMed Web of Science ®Google Scholar
• Puri BK, Taylor DG, Alcock ME. 1995. Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder. Br J Clin Pract 49:333–334.
   PubMedGoogle Scholar
• Puzynski S, Klosiewicz L. 1984a. Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders. Psychopharmacol Bull 20:151–159.
   Google Scholar
• Puzynski S, Klosiewicz L. 1984b. Valproic acid amide in the treatment of affective and schizoaffective disorders. J Affect Disord 6:115–121.
   Google Scholar
• Quiroz JA, Yatham LN, Palumbo JM, Karcher K, Kushner S, Kusumakar V. 2010. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry 68:156–162.
   PubMed Web of Science ®Google Scholar
• Quitkin F, Rifkin A, Kane J, Ramos-Lorenzi JR, Klein DF. 1978. Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am J Psychiatry 135:570–572.
   Google Scholar
• Quitkin FM, Kane JM, Rifkin A, Ramos-Lorenzi JR, Saraf K, Howard A, Klein DF. 1981. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison. Psychopharmacol Bull 17:142–144.
   Google Scholar
• Rabheru K, Persad E. 1997. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42:476–484.
   PubMed Web of Science ®Google Scholar
• Raucher-Chene D, Charrel CL, de Maindreville AD, Limosin F. 2008. Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci 273:116–117.
   Google Scholar
• Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B, . 2009. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 123:81–86.
   Google Scholar
• Riedel M, Musil R, Seemuller F, Spellmann I, Moller HJ, Schennach-Wolff R. 2010. Safety evaluation of zotepine for the treatment of schizophrenia. Expert Opin Drug Saf 9:659–666.
   PubMed Web of Science ®Google Scholar
• Riemann D, Gann H, Hohagen F, Bahro M, Muller WE, Berger M. 1993. The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls. Neuropsychobiology 27:163–170.
   Google Scholar
• Roy-Byrne PP, Post RM, Uhde TW, Porcu T, Davis D. 1985. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl 317:1–34.
   PubMedGoogle Scholar
• Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, . 2010. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123:225–233.
   PubMed Web of Science ®Google Scholar
• Runge C, Grunze H. 2004. Jährliche Krankheitskosten bipolarer Störungen in Deutschland. Nervenarzt 75:896–903.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, . 2005. Effects of 12 months of vagus nerve stimulation in treatment–resistant depression: a naturalistic study. Biol Psychiatry 58:355–363.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A. 2010. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 13:617–622.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. 2001. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 3:63–67.
   PubMed Web of Science ®Google Scholar
• Ryves WJ, Harwood AJ. 2001. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720–725.
   PubMed Web of Science ®Google Scholar
• Sachdev PS. 1986. Lithium potentiation of neuroleptic-related extrapyramidal side effects. Am J Psychiatry 143:942.
   PubMed Web of Science ®Google Scholar
• Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. 2000. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec Report 1–104.
   Google Scholar
• Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, . 2007. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New Engl J Med 356:1711–1722.
   PubMed Web of Science ®Google Scholar
• Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, . 2007. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 10(Suppl 1):1–207.
   Google Scholar
• Schneck CD. 2002. Bipolar disorder in neurologic illness. Curr Treat Options Neurol 4:477–486.
   PubMedGoogle Scholar
• Scott J, Colom F, Vieta E. 2007. A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol 10:123–129.
   PubMed Web of Science ®Google Scholar
• Scott J, Colom F, Popova E, Benabarre A, Cruz N, Valenti M, . 2009. Long-term mental health resource utilization and cost of care following group psychoeducation or unstructured group support for bipolar disorders: a cost-benefit analysis. J Clin Psychiatry 70:378–386.
   Google Scholar
• Seemuller F, Forsthoff A, Dittmann S, Born C, Bernhard B, Severus WE, Grunze H. 2005. The safety and tolerability of atypical antipsychotics in bipolar disorder. Expert Opin Drug Saf 4:849–868.
   PubMedGoogle Scholar
• Seo HJ, Chiesa A, Lee SJ, Patkar AA, Han C, Masand PS, . 2011. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications. Clin Neuropharmacol 34:39–47.
   PubMed Web of Science ®Google Scholar
• Serretti A, Artioli P. 2003. Predicting response to lithium in mood disorders: role of genetic polymorphisms. Am J Pharmacogenomics 3:17–30.
   Google Scholar
• Severus WE, Littman AB, Stoll AL. 2001. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 9:280–293.
   Web of Science ®Google Scholar
• Severus WE, Kleindienst N, Evoniuk G, Bowden C, Moller HJ, Bohus M, . 2009. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. J Affect Disord 115:466–470.
   PubMedGoogle Scholar
• Severus WE, Lipkovich IA, Licht RW, Young AH, Greil W, Ketter T, . 2010. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005. Eur Psychiatry 25:443–449.
   Google Scholar
• Shelton RC. 2006. Olanzapine/fluoxetine combination for bipolar depression. Expert Rev Neurother 6:33–39.
   PubMedGoogle Scholar
• Shukla S, Godwin CD, Long LE, Miller MG. 1984. Lithium-carbamazepine neurotoxicity and risk factors. Am J Psychiatry 141:1604–1606.
   PubMed Web of Science ®Google Scholar
• Simon GE, Savarino J, Operskalski B, Wang PS. 2006. Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47.
   PubMed Web of Science ®Google Scholar
• Singh V, Mintz J, Tohen M. 2012. Novel strategies to improve generalizability of maintenance trial results in Bipolar Disorder (BD). Bipolar Disord 14(Suppl 1):13–14.
   Google Scholar
• Smith LA, Cornelius V, Warnock A, Bell A, Young AH. 2007. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 9:394–412.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Keitner GI, Ryan CE, Miller IW. 1998. Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. J Clin Psychopharmacol 18:38–49.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Leon AC, Coryell WH, Endicott J, Li C, Fiedorowicz JG, Boyken L, Keller MB. 2010. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 67:339–347.
   PubMed Web of Science ®Google Scholar
• Spina E, Pisani F, Perucca E. 1996. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31:198–214.
   PubMed Web of Science ®Google Scholar
• Staiano AE, Reeder BA, Elliott S, Joffres MR, Pahwa P, Kirkland SA, . 2012. Body mass index versus waist circumference as predictors of mortality in Canadian adults. Int J Obes (London) 36:1450–1454.
   Web of Science ®Google Scholar
• Stallone F, Shelley E, Mendlewicz J, Fieve RR. 1973. The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 130:1006–1010.
   PubMed Web of Science ®Google Scholar
• Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, . 1999. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407–412.
   PubMed Web of Science ®Google Scholar
• Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, . 2009. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. Br Med J 339:b2880 (doi: 10.1136/bmj.b2880).
   PubMed Web of Science ®Google Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. 1993. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv Rev Psychiatry 1:131–144.
   PubMed Web of Science ®Google Scholar
• Suppes T, Phillips KA, Judd CR. 1994. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 36:338–340.
   PubMedGoogle Scholar
• Suppes T, McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, . 2004. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. Int Clin Psychopharmacol 19:173–174.
   PubMed Web of Science ®Google Scholar
• Suppes T, Brown E, Schuh LM, Baker RW, Tohen M. 2005. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post-hoc analyses of 47-week data. J Affect Disord 89:69–77.
   PubMed Web of Science ®Google Scholar
• Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, . 2007. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network. Int Clin Psychopharmacol 22:376–381.
   Google Scholar
• Suppes T, Vieta E, Liu S, Brecher M, Paulsson B. 2009. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 166:476–488.
   PubMed Web of Science ®Google Scholar
• Szabo CP. 1993. Depot flupenthixol-induced mania. S Afr Med J 83:442.
   Google Scholar
• Szegedi A, Calabrese JR, Stet L, Mackle M, Zhao J, Panagides J. 2012. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension. J Clin Psychopharmacol 32:46–55.
   PubMed Web of Science ®Google Scholar
• The World Health Organisation. 2002. The World Health Report 2001, Mental Health: New understanding, new hope. Chapter 2: Burden of mental and behavioural disorder. (Electronic Citation: http://www.who.int/whr/2001/main/en/pdf/GGTSPU-1368-326547-DAT/chapter2.en.pdf).
   Google Scholar
• Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. 1996. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29:103–107.
   PubMed Web of Science ®Google Scholar
• Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, . 2000. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 157:220–228.
   PubMed Web of Science ®Google Scholar
• Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, . 2002a. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 159:1011–1017.
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, . 2002b. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62–69.
   PubMed Web of Science ®Google Scholar
• Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, . 2003a. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 160:1263–1271.
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, . 2003b. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 60:1079–1088.
   PubMed Web of Science ®Google Scholar
• Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, . 2003c. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 160:2099–2107.
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, . 2004. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 184:337–345.
   PubMed Web of Science ®Google Scholar
• Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, . 2005. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 162:1281–1290.
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, . 2006. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247–256.
   PubMed Web of Science ®Google Scholar
• Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, . 2008. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 192:135–143.
   PubMed Web of Science ®Google Scholar
• Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, . 2009a. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 11:453–473.
   PubMed Web of Science ®Google Scholar
• Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL. 2009b. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo–controlled study of bipolar 1 disorder. J Affect Disord 116:43–50.
   PubMed Web of Science ®Google Scholar
• Tredget J, Kirov A, Kirov G. 2010. Effects of chronic lithium treatment on renal function. J Affect Disord 126:436–440.
   PubMed Web of Science ®Google Scholar
• Tural U, Onder E. 2010. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death. Psychiatry Clin Neurosci 64:79–87.
   PubMed Web of Science ®Google Scholar
• Ulcickas YM, Delorenze G, Quesenberry CP Jr, Tsai AL, Phillips S, Willey VJ, . 2010. Epidemiologic study of aripiprazole use and the incidence of suicide events. Pharmacoepidemiol Drug Saf 19:1124–1130.
   Google Scholar
• Undurraga J, Baldessarini RJ, Valenti M, Pacchiarotti I, Tondo L, Vazquez G, Vieta E. 2012. Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord 139:89–93.
   PubMed Web of Science ®Google Scholar
• US Food & Drug Administration. 1975. FDA pregnancy categories. (Electronic Citation: http://depts.washington.edu/druginfo/Formulary/Pregnancy.pdf).
   Google Scholar
• US Food & Drug Administration. 2008. Statistical review and evaluation: antiepileptic drugs and suicidality (12-4-2012).
   Google Scholar
• Valenti M, Pacchiarotti I, Rosa AR, Bonnin CM, Popovic D, Nivoli AM, . 2011. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord 13:145–154.
   Google Scholar
• Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. 1994. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 35:181–188.
   PubMed Web of Science ®Google Scholar
• van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, . 2009. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 70:223–231.
   PubMed Web of Science ®Google Scholar
• van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, . 2011. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 13:111–117.
   PubMedGoogle Scholar
• Vencovsky E, Soucek K, Kabes J. 1984. Prophylactic effect of dipropylacetamide in patients with bipolar affective disorder. In: Emrich HM, Okuma T, Müller AA, editors. Anticonvulsants in affective disorders. Amsterdam: Excerpta Medica. p 66–67.
   Google Scholar
• Vernon AC, Natesan S, Crum WR, Cooper JD, Modo M, Williams SC, Kapur S. 2012. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry 71:855–863.
   Google Scholar
• Vieta E, Cruz N. 2012. Head to head comparisons as an alternative to placebo-controlled trials. Eur Neuropsychopharmacol 22:800–803.
   PubMed Web of Science ®Google Scholar
• Vieta E, Grunze H. 2011. Bipolar disorder – a focus on depression. New Engl J Med 364:1581.
   Google Scholar
• Vieta E, Suppes T. 2008. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord 10:163–178.
   PubMed Web of Science ®Google Scholar
• Vieta E, Parramon G, Padrell E, Nieto E, Martinez-Aran A, Corbella B, . 2002. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 4:335–340.
   PubMed Web of Science ®Google Scholar
• Vieta E, Sanchez-Moreno J, Goikolea JM, Colom F, Martinez-Aran A, Benabarre A, . 2004. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. J Clin Psychopharmacol 24:374–378.
   PubMed Web of Science ®Google Scholar
• Vieta E, Manuel GJ, Martinez-Aran A, Comes M, Verger K, Masramon X, . 2006. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. J Clin Psychiatry 67:473–477.
   PubMed Web of Science ®Google Scholar
• Vieta E, Cruz N, Garcia-Campayo J, de AR, Manuel CJ, Valles V, . 2008a. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Int J Neuropsychopharmacol 11:445–452.
   PubMed Web of Science ®Google Scholar
• Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P. 2008b. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. World J Biol Psychiatry 9:219–224.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. 2008c. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109:251–263.
   PubMed Web of Science ®Google Scholar
• Vieta E, T'joen C, McQuade RD, Carson WH Jr, Marcus RN, Sanchez R, . 2008d. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Am J Psychiatry 165:1316–1325.
   PubMed Web of Science ®Google Scholar
• Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ. 2009a. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord 119:22–27.
   PubMed Web of Science ®Google Scholar
• Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ. 2009b. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord 119:22–27.
   PubMed Web of Science ®Google Scholar
• Vieta E, Pacchiarotti I, Valenti M, Berk M, Scott J, Colom F. 2009c. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep 11:494–502.
   PubMed Web of Science ®Google Scholar
• Vieta E, Murru A, Pueyo MJ. 2010a. Guia sobre el maneig del trastorn bipolar a Catalunya (Guidelines on the management of bipolar disorder in Catalunya). (Electronic Citation: http://www.gencat.cat/salut/depsan/units/aatrm/pdf/guia_trastorn_bipolar_aiaqs_2010ca.pdf).
   Google Scholar
• Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN. 2010b. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Curr Med Res Opin 26:1485–1496.
   PubMed Web of Science ®Google Scholar
• Vieta E, Gunther O, Locklear J, Ekman M, Miltenburger C, Chatterton ML, . 2011. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 14:1029–1049.
   PubMed Web of Science ®Google Scholar
• Vieta E, Montgomery S, Sulaiman AH, Cordoba R, Huberlant B, Martinez L, Schreiner A. 2012a. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder. Eur Neuropsychopharmacol 22:825–835.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Ekholm B, Udd M, Gustafsson U. 2012b. Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder. J Affect Disord 142:36–44.
   PubMed Web of Science ®Google Scholar
• Viguera AC, Koukopoulos A, Muzina DJ, Baldessarini RJ. 2007. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry 68(Suppl 9):29–33.
   Google Scholar
• Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D, . 2012. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry 27:129–141.
   PubMed Web of Science ®Google Scholar
• Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM. 1987. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 150:180–182.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, . 2006. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 20:219–231.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B. 2011. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: a randomized controlled study). J Clin Psychiatry 72;1452–1464.
   PubMed Web of Science ®Google Scholar
• Wingo AP, Harvey PD, Baldessarini RJ. 2009. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 11:113–125.
   PubMed Web of Science ®Google Scholar
• Woo YS, Bahk WM, Chung MY, Kim DH, Yoon BH, Lee JH, . 2011. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. Hum Psychopharmacol 26:543–553.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 1992. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO.
   Google Scholar
• Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. 2003. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 182:141–147.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, . 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11:225–255.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Vieta E, Leucht S, Baldessarini RJ. 2011. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology 36:375–389.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, . 2004. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161:608–620.
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Ueda N, Shinkai K, Nakamura J. 2006. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium. Pharmacopsychiatry 39:233–234.
   Google Scholar
• Young AH. 2011. More good news about the magic ion: lithium may prevent dementia. Br J Psychiatry 198:336–337.
   Google Scholar
• Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, . 2010. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71:150–162.
   PubMed Web of Science ®Google Scholar
• Young AH, Rigney U, Shaw S, Emmas C, Thompson JM. 2011. Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord 133:450–456.
   PubMed Web of Science ®Google Scholar
• Young AH, McElroy SL, Olausson B, Paulsson B. 2012. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. World J Biol Psychiatry2012 Mar 12. [Epub ahead of print].
   Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Tohen M. 2004. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 161:169–171.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Tohen M, Banov MD, Weiss MK, Cole JO. 1995. Is clozapine a mood stabilizer? J Clin Psychiatry 56:108–112.
   PubMed Web of Science ®Google Scholar
• Zarin D, Pincus HA, McIntyre JS. 2002. APA practice guideline for the treatment of patients with bipolar disorder. (Electronic Citation: http://www.psych.org/clin_res/pg_bipolar.cfm).
   Google Scholar
• Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, . 2011. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model. J Alzheimers Dis 24:739–749.
   PubMedGoogle Scholar
• Zimmerman M, Martinez JA, Attiullah N, Friedman M, Toba C, Boerescu DA, Rahgeb M. 2012. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? J Clin Psychiatry 73:790–795.
   PubMed Web of Science ®Google Scholar
• Zis AP, Grof P, Webster M, Goodwin FK. 1980. Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 16:47–49.
   PubMedGoogle Scholar